A bioinformatics spinoff company from Case Western Reserve University has reached an exclusive option agreement to license technology from the university. The company, NeoProteomics, was co-founded by Mark Chance, director of Case Center for Proteomics and Bioinformatics. NeoProteomics focuses on the identification and validation of biomarkers, proteins in the blood that can indicate the presence […]
Case Western Reserve University researchers and their collaborators in England have taken the first image of an open K+ channel — the beginning of a better understanding of how and why heart and nerve drugs work for some people and not for others. The image and its analysis — featured in the July issue of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mark Chance learned to love science by hanging around the University of Pennsylvania laboratory of his uncle, Britton Chance. Yesterday, Mark Chance, a physiology and biophysics professor at Case Western Reserve University School of Medicine, accepted $25,000 grant from the Innovation Fund of the Lorain County Community College Foundation for commercializatio efforts of his company, NeoProteomics Inc. Chance belongs to a generation of academic researchers who believe their discoveries find their highest purpose in helping patients.
The five-year grant will help keep the Case West Reserve University facility open through 2014 so it can continue its work helping researchers investigate proteins and other molecules that could lead to designer drugs.
The grant is important for the school because of its significance and its size. The School of Dental Medicine has spent the last decade rebuilding its research program, and this grant from the National Institutes of Health's National Institute for Dental and Craniofacial Research is the largest in the school's 117-year history, according to a press release from the school.